| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/05/2007 | US7227033 Crystalline polymorph of the anhydrous form in synergistic combination with another active ingredient to enhance drug delivery; antidiabetic agents |
| 06/05/2007 | US7226998 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/05/2007 | US7226952 Gel composition and its use in cosmetic compositions and the like |
| 06/05/2007 | US7226932 Self-emulsifying drug delivery system |
| 06/05/2007 | US7226914 Administering sulfated polysaccharide such as cellulose sulfate, dextran sulfate, dermatan sulfate, chondroitin sulfate, pentosan sulfate, fucoidin, mannan sulfate, dextrin sulfate, curdlan sulfate, chitin sulfate, heparin or heparin sulfate for therapy and prphylaxis of fungal infection |
| 06/05/2007 | US7226757 Adding to the protein an aqueous solution of a charged polymer to reduce intermolecular or intramolecular interactions between positively and negatively charged domains; refolding |
| 06/05/2007 | US7226748 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 06/05/2007 | US7226636 Gold-coated nanoparticles for use in biotechnology applications |
| 06/05/2007 | US7226620 and a binder comprising a polyvinylpyrollidone, carrageenan, or a guar gum; chewable oral dosage form |
| 06/05/2007 | US7226618 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 06/05/2007 | US7226617 Thermosensitive and biodegradable microgel and a method for the preparation thereof |
| 06/05/2007 | US7226616 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 06/05/2007 | US7226615 kit for forming a solid cellular foam proteinaceous biopolymeric material comprising separate reactable aliquot portions; employed to grow tissue and for achieving hemostasis |
| 06/05/2007 | US7226614 segmented; sustained release; for treatment of allergies |
| 06/05/2007 | US7226611 Glycosaminoglycan/collagen complexes and use thereof |
| 06/05/2007 | US7226601 binds to both the T cell receptor and an MHC class II antigen; superantigen peptide and affinity counterpart are covalently linked; conjugates have the ability to activate and direct T-lymphocytes |
| 06/05/2007 | US7226595 Conjugated antigen for use as tool in the treatment of cancer |
| 06/05/2007 | US7226589 Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor |
| 06/05/2007 | US7226586 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 06/05/2007 | CA2286003C Phosphate-binding polymer preparation |
| 06/05/2007 | CA2262922C Polymers for delivering nitric oxide in vivo |
| 06/05/2007 | CA2258990C Use of oxidized cellulose and complexes thereof for chronic wound healing |
| 06/05/2007 | CA2243577C Methods for purification and use of erythropoietin binding protein |
| 06/01/2007 | CA2568472A1 Polymeric compositions for controlled release or delivery of pharmacologically active agents |
| 05/31/2007 | WO2007062177A2 Molecular conjugate |
| 05/31/2007 | WO2007061900A1 High-potency sweetener composition with antioxidant and compositions sweetened therewith |
| 05/31/2007 | WO2007061679A1 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 05/31/2007 | WO2007061028A1 Gel composition for sterilization |
| 05/31/2007 | WO2007060802A1 Solid pharmaceutical preparation and pharmaceutical preparation composition |
| 05/31/2007 | WO2007060628A1 Spray-dried chitin nanofibrils, method for production and uses thereof |
| 05/31/2007 | WO2007060512A2 Compositions containing topical active agents and pentylene glycol |
| 05/31/2007 | WO2007060192A1 Protein constructs designed for targeting and lysis of cells |
| 05/31/2007 | WO2007060105A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007059997A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/31/2007 | WO2007059931A1 New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions |
| 05/31/2007 | WO2007059852A1 Ph-switchable transmembrane peptides as stimulators of membrane fusion |
| 05/31/2007 | WO2007039448A3 Use of conjugates of doxorubicin with lactosaminated albumin |
| 05/31/2007 | WO2007039254A3 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 05/31/2007 | WO2007031520A3 Use of octenidine dihydrochloride in semisolid preparations |
| 05/31/2007 | WO2007025763A3 Highly cross-linked reagents for modifying biopharmaceuticals, production and use thereof |
| 05/31/2007 | WO2007019549A3 Composition and method for use in cartilage affecting conditions |
| 05/31/2007 | WO2007018583A3 Human growth hormone conjugated with biocompatible polymer |
| 05/31/2007 | WO2007016560A9 Methods for preparing carbonate esters of poly(etylene glycol) |
| 05/31/2007 | WO2007016160A3 Svct2 transporters expressed in blood brain barrier cells |
| 05/31/2007 | WO2007016146A3 Method for retarding systemic delivery rate for easily absorbable active agents |
| 05/31/2007 | WO2006135930A3 Transmucosal delivery of peptide derivatives |
| 05/31/2007 | WO2006069388A3 Stabilized polymeric thiol reagents |
| 05/31/2007 | WO2006066891A3 Conjugates of insulin-like growth factor-1 (igf-1) and poly(ethylene glycol) |
| 05/31/2007 | WO2006056889A3 Method and composition for enhancing anti-angiogenic therapy |
| 05/31/2007 | WO2006031353A3 Vascular endothelial growth factor fusion constructs and uses thereof |
| 05/31/2007 | WO2006015318A3 Antibody conjugated to a drug moiety via a poptidic linker |
| 05/31/2007 | WO2005032483A3 Polysaccharides for pulmonary delivery of active agents |
| 05/31/2007 | US20070123699 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 05/31/2007 | US20070123696 G-csf conjugates |
| 05/31/2007 | US20070123693 Polymer derivatives |
| 05/31/2007 | US20070123691 polyoxyalkylene glycol or polyvinyl alcohol with a terminal azide moiety |
| 05/31/2007 | US20070123646 Protein-polymer conjugates and synthesis thereof |
| 05/31/2007 | US20070123593 Pharmaceutical composition comprising 5-methyl-2(2'-chloro-6'-fluoroanilino)phenylacetic acid |
| 05/31/2007 | US20070123554 Pyrazoloacrydone derivative-containing solution |
| 05/31/2007 | US20070123457 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 05/31/2007 | US20070123450 oxidized glutathione-based compound having a stabilized disulfide bond and either platinum and palladium |
| 05/31/2007 | US20070122486 Nanoparticulate insulin |
| 05/31/2007 | US20070122485 Organic compounds |
| 05/31/2007 | US20070122475 Taste masking composition |
| 05/31/2007 | US20070122474 Pharmaceutical preparation comprising an active dispersed on a matrix |
| 05/31/2007 | US20070122467 Anaesthetic formulations |
| 05/31/2007 | US20070122464 Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis |
| 05/31/2007 | US20070122458 Nicotine and Chocolate Compositions |
| 05/31/2007 | US20070122457 Nicotine and Chocolate Compositions |
| 05/31/2007 | US20070122456 Nicotine and Cocoa Powder Compositions |
| 05/31/2007 | US20070122455 drug delivery devices in the form of self-supporting films comprising water-soluble polymers, active component selected from cosmetics, drugs, vitamins and/or mixtures and release agents |
| 05/31/2007 | US20070122454 Skin moisturizing agent for oral intake and functional foods and drinks |
| 05/31/2007 | US20070122453 Moderating the effect of endotoxins |
| 05/31/2007 | US20070122451 Biogically non-degradable peptides, angiostensin converting enzyme inhibitor, drug and functional food |
| 05/31/2007 | US20070122446 Implants for treatment of symptomatic or degenerated intervertebral discs |
| 05/31/2007 | US20070122435 Topical dapsone for the treatment of acne |
| 05/31/2007 | US20070122433 Less painful immunogenic composition of a hydrophobic protein; solubilizing hydrophobic protein with a zwitterionic detergent to make a composition that is then altered; meningitis or gonorrhea |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122402 Immunoglobulin preparations having increased stability |
| 05/31/2007 | US20070122398 Encapsulated hydrophilic compounds |
| 05/31/2007 | US20070122397 Probiotic storage and delivery |
| 05/31/2007 | US20070122354 possess superior aerosol properties, even in the absence of stabilizing carriers or excipients; inhalants; when administered to the deep lung, are useful for treating allergic diseases, such as asthma, atopy, and atopic dermatitis |
| 05/31/2007 | DE102005056393A1 Pressure-sensitive adhesive, useful particularly for plasters and transdermal drug-delivery systems, contains specific multicyclic hydrocarbon substituted by polar groups |
| 05/31/2007 | CA2631005A1 Molecular conjugate |
| 05/31/2007 | CA2630771A1 Protein constructs designed for targeting and lysis of cells |
| 05/31/2007 | CA2630696A1 Keratin-binding effector molecules and method for the production thereof by coupling keratin-binding polypeptides with effector molecules that support carboxylic groups or sulfonic acid groups |
| 05/31/2007 | CA2630142A1 High-potency sweetener composition with antioxidant and compositions sweetened therewith |
| 05/31/2007 | CA2629147A1 Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin |
| 05/31/2007 | CA2629073A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | CA2628736A1 New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions |
| 05/31/2007 | CA2628126A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790687A2 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 05/30/2007 | EP1790665A1 Process for producing water-soluble hyaluronic acid modification |
| 05/30/2007 | EP1790664A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/30/2007 | EP1790657A1 pH-switchable transmembrane peptides as stimulators of membrane fusion |
| 05/30/2007 | EP1790654A1 Peptide capable of binding to insulin-binding protein and adsorbent |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1790358A1 Protein constructs designed for targeting and lysis of cells |
| 05/30/2007 | EP1790357A2 Perorally administrable antimicrobial composition |